Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 37Myelodysplastic Syndromes 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 11Hematologic Neoplasms 10Lymphoma 9Hodgkin Disease 9Anemia, Refractory, with Excess of Blasts 9Myeloproliferative Disorders 8Multiple Myeloma 8Lymphoma, Non-Hodgkin 8Leukemia, Myelomonocytic, Chronic 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Biphenotypic, Acute 7Graft vs Host Disease 7Leukemia, Lymphocytic, Chronic, B-Cell 6Primary Myelofibrosis 5Neuroblastoma 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid 4Congenital Abnormalities 4Anemia, Aplastic 4Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3Polycythemia Vera 3Lymphoproliferative Disorders 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

venetoclax 1fludarabine 1Influenza Vaccines 1Decitabine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Older Patients × Busulfan × 1 year × Clear all
NCT07052422 2025-07-04

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Not yet recruiting
160 enrolled
Other neoplasm

Older Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡